Bulletin
Investor Alert

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 5:20 p.m.

/zigman2/quotes/206690250/composite

$

90.35

Change

0.00 0.00%

Volume

Volume 231,939

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Previous close

$ 89.34

$ 90.35

Change

+1.01 +1.13%

Day low

Day high

$87.88

$90.87

Open

52 week low

52 week high

$82.51

$120.54

Open

Michael A. DesJardin

Presently, Michael A. DesJardin is Executive VP-Technical Operations & Quality at Horizon Therapeutics Plc.

He previously held the position of Senior Vice President-Product Development at Jazz Pharmaceuticals Plc, Executive Director-Implant Research & Development at ALZA Corp. and Senior Vice President-Technical Operations at Horizon Pharmaceutical LLC.

Michael A. DesJardin received an undergraduate degree from the University of California, Berkeley.

Transactions

Date Shares Transaction Value
04/12/2022 11,064   Disposition at $113.6 per share. 1,256,871
04/12/2022 9,150   Disposition at $112.55 per share. 1,029,833
03/02/2022 13,518   Disposition at $97.42 per share. 1,316,924
03/02/2022 21,482   Disposition at $97.05 per share. 2,084,829
01/21/2022 1,825   Derivative/Non-derivative trans. at $86.42 per share. 157,717
01/21/2022 3,679   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 41,276   Derivative/Non-derivative trans. at $101.84 per share. 4,203,548
01/05/2022 32,301   Award at $0 per share. 0
01/05/2022 53,734   Derivative/Non-derivative trans. at $0 per share. 0
07/28/2021 3,599   Derivative/Non-derivative trans. at $102.5 per share. 368,898
07/28/2021 7,257   Award at $0 per share. 0
02/26/2021 1,099   Disposition at $91.83 per share. 100,922
02/24/2021 5,158   Disposition at $87.2 per share. 449,778
02/24/2021 10,786   Disposition at $95 per share. 1,024,670
02/21/2021 1,082   Derivative/Non-derivative trans. at $88.87 per share. 96,158
02/21/2021 2,182   Derivative/Non-derivative trans. at $0 per share. 0
02/17/2021 975   Derivative/Non-derivative trans. at $87.17 per share. 84,991
02/17/2021 1,965   Award at $0 per share. 0
02/11/2021 10,786   Disposition at $90 per share. 970,740
02/02/2021 4,530   Disposition at $85 per share. 385,050
01/21/2021 1,824   Derivative/Non-derivative trans. at $77.43 per share. 141,233
01/21/2021 3,678   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2021 50,658   Derivative/Non-derivative trans. at $36.1 per share. 1,828,754
01/05/2021 60,313   Award at $0 per share. 0
01/05/2021 41,615   Derivative/Non-derivative trans. at $0 per share. 0
12/10/2020 5,909   Disposition at $69.64 per share. 411,503
12/05/2020 2,906   Derivative/Non-derivative trans. at $71.72 per share. 208,419
12/05/2020 5,861   Derivative/Non-derivative trans. at $0 per share. 0
05/07/2020 23,159   Derivative/Non-derivative trans. at $14.93 per share. 345,763
05/06/2020 8,979   Disposition at $42 per share. 377,118
05/06/2020 8,980   Disposition at $41.19 per share. 369,887
05/05/2020 8,980   Disposition at $38 per share. 341,240
02/21/2020 1,082   Derivative/Non-derivative trans. at $35.5 per share. 38,411
02/21/2020 2,181   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2020 5,074   Derivative/Non-derivative trans. at $36.06 per share. 182,969
02/19/2020 10,232   Award at $0 per share. 0
01/21/2020 1,824   Derivative/Non-derivative trans. at $38.25 per share. 69,768
01/21/2020 1,864   Derivative/Non-derivative trans. at $38.25 per share. 71,298
01/21/2020 3,678   Award at $0 per share. 0
01/05/2020 24,286   Derivative/Non-derivative trans. at $36.1 per share. 876,725
01/05/2020 19,014   Award at $0 per share. 0
01/05/2020 29,520   Derivative/Non-derivative trans. at $0 per share. 0
12/05/2019 2,906   Derivative/Non-derivative trans. at $31.86 per share. 92,586
12/05/2019 5,860   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2019 1,082   Derivative/Non-derivative trans. at $21.24 per share. 22,982
02/21/2019 2,182   Derivative/Non-derivative trans. at $0 per share. 0
02/20/2019 9,429   Derivative/Non-derivative trans. at $21.54 per share. 203,101
02/20/2019 19,014   Award at $0 per share. 0
01/05/2019 8,931   Derivative/Non-derivative trans. at $20.39 per share. 182,104
01/05/2019 17,259   Derivative/Non-derivative trans. at $0 per share. 0
12/05/2018 2,027   Derivative/Non-derivative trans. at $20.25 per share. 41,047
12/05/2018 5,861   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2018 891   Derivative/Non-derivative trans. at $14.09 per share. 12,555
02/21/2018 2,181   Derivative/Non-derivative trans. at $0 per share. 0
12/05/2017 3,058   Derivative/Non-derivative trans. at $14.44 per share. 44,158
12/05/2017 5,860   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.